新的ARC Insight报告定义了Pharma Gen3包装需求
正好及时参加Interphex Show Arc Advisory Group发布了一份新的见解报告，分析了制药制造中GEN3包装自动化的业务驱动力。
While pharmaceutical product development costs have quadrupled in the US since 1990 patent protection is simultaneously eroding. Therefore ARC notes that time to market is more critical than ever and packaging machine flexibility is playing a key role. For a blockbuster drug every day’s delay in reaching the market can cost $1 million.
同样格式更改正在上升,很多大小re falling especially for the pharma industry’s contract packaging partners. According to ARC new delivery systems – such as transfer patches and future technologies such as time release microchips – will all require increasing flexibility in packaging machinery.
法规合规性问题正在随着验证编码单元的剂量和文档要求而扩大，严重依赖于自动化系统。
Pricing pressure is mounting on a global basis both due to competition and socio-political issues. As a result pharma producers are looking for operational efficiencies in new places. And taking a lesson from consumer goods packagers they are capturing both cost savings and marketing opportunities through packaging.
gen3在制药中的“最前沿”
ARC asserts that Gen3 packaging automation can play a key role in developing best practices for many applications. For example the Insight identifies end of line packaging as difficult to validate and a frequent source of FDA audits and citations.
From a performance perspective ARC notes the need for streamlining of control capabilities on a single platform instead of separate PLCs HMI and motion controls. This is one of the essential aspects of Gen3 packaging automation and also one of the least clearly understood.
集成控制的好处包括一套通用的开发和集成工具。但是它们还减少了FDA验证要求并提高用户的机器性能。
弧看到internati采用IEC 61131 - 3onal language standard for motion and logic as very important. This is because standardized programming simplifies machinery design operation and troubleshooting. And by using validated off-the-shelf software libraries validation is further simplified.
The analysts note the many benefits of networking machines as intelligence is being distributed to increasingly modular machine designs.
A ‘renaissance of innovation’
ARC’s view of the global machinery market is encouraging for pharma packagers seeking new solutions.
One electromechanical innovation is the emerging use of specialized servomotors for filling and capping lines to reduce contamination and accommodate format changes. Servos are also being used to increase the productivity of blister packaging lines and tool-less changeover technologies.
机器人技术的使用增加使机器更紧凑和可重编程。使用机器人容易重新配置的包装单元可以根据ARC代替专用的线性配置。
In conclusion ARC recommends that users base their buying decisions on modularity and adaptability to protect their investment.
For a free copy of the new ARC Advisory Group report Pharmaceutical Business Seeks Generation 3 Packaging Machinery visitwww.elau.com/interphexor visit ELAU at Interphex Booth 2350 Jacob Javits Convention Center New York March 31 to April 2.
